Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Beta Drugs Ltd.

GO
Market Cap. ( ₹ in Cr. ) 1140.99 P/BV 5.16 Book Value ( ₹ ) 218.94
52 Week High/Low ( ₹ ) 2000/1099 FV/ML 10/1 P/E(X) 26.90
Book Closure 26/03/2025 EPS ( ₹ ) 42.02 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]362.36295.71227.11183.84116.12
Total Operating Revenues362.36295.71227.11183.84116.12
      
Other Income6.441.360.750.760.50
Total Revenue368.79297.07227.87184.59116.62
      
EXPENSES     
Cost Of Materials Consumed175.78167.65110.4096.2160.55
Operating And Direct Expenses40.6231.7924.2917.7813.40
Changes In Inventories Of FG,WIP And Stock-In Trade-4.42-18.24-4.71-1.75-1.77
Employee Benefit Expenses33.9225.8922.7015.9110.88
Finance Costs6.992.822.411.902.42
Depreciation And Amortisation Expenses12.519.7810.417.256.87
Other Expenses41.8628.6321.3112.998.31
Total Expenses307.25248.32186.81150.29100.67
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax61.5448.7541.0634.3015.95
      
Exceptional Items-4.570.000.000.000.00
Profit/Loss Before Tax56.9748.7541.0634.3015.95
      
Tax Expenses-Continued Operations     
Current Tax14.9712.5310.869.514.71
Deferred Tax-0.42-0.21-0.52-0.03-0.48
Total Tax Expenses14.5512.3210.349.474.23
Profit/Loss After Tax And Before ExtraOrdinary Items42.4236.4430.7224.8311.72
      
Profit/Loss From Continuing Operations42.4236.4430.7224.8311.72
      
Profit/Loss For The Period42.4236.4430.7224.8311.72
Consolidated Profit/Loss After MI And Associates42.4236.4430.7224.8311.72
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)42.0237.9031.9525.8212.20
Diluted EPS (Rs.)42.0237.9031.9525.8212.20
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]362.36
Total Operating Revenues362.36
Other Income6.44
Total Revenue368.79
EXPENSES 
Cost Of Materials Consumed175.78
Operating And Direct Expenses40.62
Changes In Inventories Of FG,WIP And Stock-In Trade-4.42
Employee Benefit Expenses33.92
Finance Costs6.99
Depreciation And Amortisation Expenses12.51
Other Expenses41.86
Total Expenses307.25
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax61.54
Exceptional Items-4.57
Profit/Loss Before Tax56.97
Tax Expenses-Continued Operations 
Current Tax14.97
Deferred Tax-0.42
Total Tax Expenses14.55
Profit/Loss After Tax And Before ExtraOrdinary Items42.42
Profit/Loss From Continuing Operations42.42
Profit/Loss For The Period42.42
Consolidated Profit/Loss After MI And Associates42.42
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)42.02
Diluted EPS (Rs.)42.02
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.